These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30897285)

  • 21. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
    Shi BB; Zhang XH; Wang HJ; Li HZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A
    IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease.
    Teofili L; Di Febo AL; Pierconti F; Maggiano N; Bendandi M; Rutella S; Cingolani A; Di Renzo N; Musto P; Pileri S; Leone G; Larocca LM
    Blood; 2001 Feb; 97(4):1063-9. PubMed ID: 11159538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
    Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
    Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Met expression in gastric cancer with liver metastasis.
    Amemiya H; Kono K; Itakura J; Tang RF; Takahashi A; An FQ; Kamei S; Iizuka H; Fujii H; Matsumoto Y
    Oncology; 2002; 63(3):286-96. PubMed ID: 12381909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
    Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.
    Seneviratne D; Ma J; Tan X; Kwon YK; Muhammad E; Melhem M; DeFrances MC; Zarnegar R
    Gastroenterology; 2015 Jan; 148(1):181-191.e17. PubMed ID: 25244939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
    Galimi F; Torti D; Sassi F; Isella C; Corà D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A
    Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.
    Firtina Karagonlar Z; Koc D; Iscan E; Erdal E; Atabey N
    Cancer Sci; 2016 Apr; 107(4):407-16. PubMed ID: 26790028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M; Vitarelli E; Grosso M; Alesci S; Benvenga S; Trimarchi F; Barresi G
    Eur J Histochem; 2004; 48(3):291-7. PubMed ID: 15590419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma.
    Edakuni G; Sasatomi E; Satoh T; Tokunaga O; Miyazaki K
    Pathol Int; 2001 Mar; 51(3):172-8. PubMed ID: 11328532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
    Takeuchi H; Bilchik A; Saha S; Turner R; Wiese D; Tanaka M; Kuo C; Wang HJ; Hoon DS
    Clin Cancer Res; 2003 Apr; 9(4):1480-8. PubMed ID: 12684423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
    Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
    Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model.
    Elliott VA; Rychahou P; Zaytseva YY; Evers BM
    PLoS One; 2014; 9(5):e97432. PubMed ID: 24823486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
    Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR
    Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.
    Ozen E; Gozukizil A; Erdal E; Uren A; Bottaro DP; Atabey N
    PLoS One; 2012; 7(8):e42717. PubMed ID: 22912725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.